What Cancers are Treated with Next Generation TKIs?
Next generation TKIs are used to treat a variety of cancers, including but not limited to: - Lung Cancer: Agents like Osimertinib and Lorlatinib offer new options for patients with NSCLC. - Chronic Myeloid Leukemia (CML): Ponatinib is effective against CML with the T315I mutation. - Breast Cancer: TKIs like Neratinib target HER2-positive breast cancer.
